A machine learning approach to predicting new pharmaceutical successes in clinical trials

Frank Schiro; Sos Agaian

doi:10.1117/12.2619069

27 May 2022 A machine learning approach to predicting new pharmaceutical successes in clinical trials

Frank Schiro, Sos Agaian

Proceedings Volume 12100, Multimodal Image Exploitation and Learning 2022; 1210009 (2022) https://doi.org/10.1117/12.2619069
Event: SPIE Defense + Commercial Sensing, 2022, Orlando, Florida, United States

Abstract

Drug discovery and development pipelines are complex, long, and depend on several factors, including FDA trials. Recently artificial intelligence has moved from largely theoretical studies to real-world applications. The pharmaceutical industry currently faces challenges sustaining its drug development programs because of increased R&D costs and reduced efficiency. There is a critical need for time and cost-efficient strategies to analyze and interpret these data to advance human drug development prediction. Also, to predict if new drugs will pass FDA trials or not. In this study, we attempt to accomplish four tasks (1) create a reliable dependent variable to categorize drugs with minimal noise, (2) link this dependent variable to predictor variables, (3) utilize a boosted tree model with the principal component method to develop an algorithm to predict FDA trial outcomes, and (4) to develop a design matrix of regressor variables for 3500 approved and investigational drugs built with DrugBank 5.1.8 Drug Targets and Drug Categories data, as well as ATC codes from both DrugBank and ChEMBL databases. Additionally, intensive computer simulations (1) show a 91% prediction success rate over a wide range of drug categories, (2) provide new insights into predicting the success of drug development, and (3) present data that can save time and resources and help decision-making for the benefit of companies future investigation, potentially to help clinical trials and investment.

Conference Presentation

Citation Download Citation

Frank Schiro and Sos Agaian "A machine learning approach to predicting new pharmaceutical successes in clinical trials", Proc. SPIE 12100, Multimodal Image Exploitation and Learning 2022, 1210009 (27 May 2022); https://doi.org/10.1117/12.2619069

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available